Your session is about to expire
← Back to Search
Transcranial Direct Current Stimulation + Physical Exercise for Chronic Pain
N/A
Recruiting
Led By Guillaume Léonard, pht, PhD.
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
To have contraindication to TMS
To have orthopedic limitation or contraindication to physical exercise
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before intervention, follow-up 1 week after intervention, follow-up 1 month after intervention
Summary
This trial is testing whether adding transcranial direct current stimulation to physical exercises will help reduce chronic pain in elderly individuals with low corticospinal projections.
Who is the study for?
This trial is for elderly individuals with musculoskeletal chronic pain who haven't been very physically active (less than 150 minutes of exercise per week) and can maintain their current medication and lifestyle during the study. It's not suitable for those with uncontrolled heart disease, orthopedic issues preventing exercise, or contraindications to MRI, TMS, or tDCS.
What is being tested?
The trial is testing if adding transcranial direct current stimulation (tDCS) to physical exercises helps reduce chronic pain more effectively in elderly patients with low corticospinal projections compared to exercises alone.
What are the potential side effects?
Potential side effects from tDCS may include mild discomfort at the electrode site on the scalp, itching, tingling sensations during application, headache, fatigue and nausea. Physical exercise might cause muscle soreness or strain.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot undergo TMS due to health reasons.
Select...
I cannot do physical exercises due to orthopedic reasons.
Select...
I have a heart condition that is not well-managed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before intervention, follow-up 1 week after intervention, follow-up 1 month after intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before intervention, follow-up 1 week after intervention, follow-up 1 month after intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Pain intensity
Secondary study objectives
Beck anxiety inventory
Beck depression inventory
Brief pain inventory
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise + real tDCSExperimental Treatment2 Interventions
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.
For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).
Group II: Exercise + Sham tDCSPlacebo Group1 Intervention
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.
For the first week, participants will receive 5 daily sessions of sham tDCS.
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
306 Previous Clinical Trials
77,552 Total Patients Enrolled
11 Trials studying Chronic Pain
1,116 Patients Enrolled for Chronic Pain
Guillaume Léonard, pht, PhD.Principal InvestigatorUniversité de Sherbrooke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot undergo TMS due to health reasons.I have long-term pain in my muscles or bones.I cannot do physical exercises due to orthopedic reasons.You were regularly doing moderate to vigorous exercise for more than 150 minutes each week before the study.I have a heart condition that is not well-managed.You cannot have an MRI for medical reasons.You have a medical reason that makes it unsafe for you to receive tDCS treatment.
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.